Genetics Generation Advancement Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 154.8 million compared to TWD 132.41 million a year ago. Net income was TWD 4.88 million compared to TWD 7.83 million a year ago. Basic earnings per share from continuing operations was TWD 0.19 compared to TWD 0.31 a year ago. Diluted earnings per share from continuing operations was TWD 0.19 compared to TWD 0.31 a year ago.
For the nine months, sales was TWD 434.77 million compared to TWD 406.4 million a year ago. Net income was TWD 21.69 million compared to TWD 19.43 million a year ago. Basic earnings per share from continuing operations was TWD 0.85 compared to TWD 0.76 a year ago. Diluted earnings per share from continuing operations was TWD 0.85 compared to TWD 0.76 a year ago.